Lung Cancer Clinical Trials

ReadTheTrial indexes 15 studies for Lung Cancer. The most common development stage is N/A (9 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

15 clinical trials found for Lung Cancer.

Pipeline by Phase

PhaseTrialsDistribution
N/A 9
60%
Phase 2 3
20%
Phase 1 2
13%
Phase 3 1
7%

Trial Status Breakdown

Trials for Lung Cancer

IMPLEMENTING LOW-DOSE CT LUNG CANCER SCREENING IN FRANCE

NCT07513818 · NOT YET RECRUITING · N/A

The Effect of Mindfulness-Based Breathing Exercises in Lung Cancer Patients Undergoing Chemotherapy

NCT07520799 · NOT YET RECRUITING · N/A

Prediction Augmented Screening Initiative

NCT06538636 · NOT YET RECRUITING · N/A

Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigating Radiation-response and Toxicity

NCT06909201 · RECRUITING · Phase 1

Systemwide Early Notification Tool for ImmineNt Lung Cancer-1 Study: Evaluating Patient-Reported Outcomes of Artificial Intelligence Inferred Lung Cancer Risk

NCT07458425 · RECRUITING · N/A

Evaluating Large Language Models as Decision Support Agents in Pan-Cancer Tumor Boards: A Randomized Controlled Trial

NCT07504367 · RECRUITING · N/A

An Open Label, Multicenter Phase II Clinical Study on the Safety, Tolerability, and Efficacy of FH-006 Injection Combined With Other Anti-tumor Therapies in Lung Cancer Subjects

NCT07241767 · RECRUITING · Phase 2

A Phase 3 Randomized, Open-label Clinical Study to Evaluate the Pharmacokinetics and Safety of Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) Versus Intravenous Pembrolizumab, in the First-line Treatment of Participants With Metastatic Non-small Cell Lung Cancer With PD-L1 TPS 50% or Greater

NCT06698042 · ACTIVE NOT RECRUITING · Phase 3

DURABLE: Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and rEarrangements

NCT05987644 · RECRUITING · Phase 2

Bronchoscopy With and Without Needle-based Confocal Laser Endomicroscopy for Peripheral Lung Nodule Diagnosis: Protocol for a Multicenter Randomized Controlled Trial (CLEVER Trial)

NCT06079970 · RECRUITING · N/A

Comparing Outcomes for Minimally Invasive Techniques for Anatomic Lung Resection for Cancer - A Prospective, Comparative, Non-randomized, Open Label Post-market Observational Cohort Study Within Europe

NCT06038227 · RECRUITING · N/A

Use of Natural Language Processing ChatBot and Automated Continuous Activity Monitoring Via Mobile Phones for Early Detection and Management of Symptoms in Patients Undergoing Cancer Treatment

NCT05318027 · ACTIVE NOT RECRUITING · Phase 2

Screening for High Frequency Malignant Disease

NCT05117840 · ACTIVE NOT RECRUITING · N/A

Tribally Engaged Approaches to Lung Screening (TEALS)

NCT04948060 · ACTIVE NOT RECRUITING · N/A

Magnetic Resonance Guided Adaptive Stereotactic Body Radiotherapy for Lung Tumors in Ultracentral Location

NCT04925583 · ACTIVE NOT RECRUITING · Phase 1

Frequently Asked Questions

What clinical trials are available for Lung Cancer?

There are 15 clinical trials listed for Lung Cancer. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Lung Cancer trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Lung Cancer trials in?

Current Lung Cancer trials are distributed across: N/A (9), Phase 2 (3), Phase 1 (2), Phase 3 (1).

Find More Trials